BB Biotech AG announced consolidated earnings results for the first quarter ended March 31, 2020. For the quarter, the company announced operating income was CHF 0.284 million compared to CHF 902.564 million a year ago. Loss for the period was CHF 757.954 million compared to earnings for the period of CHF 889.781 million a year ago. Loss per share was CHF 13.68 compared to earnings per share of CHF 16.06 a year ago.